@RETpositive

Research, news and advocacy for caregivers and patients impacted by RET-driven cancers. Research is hope!🧬🔬

retpositive.org
Joined August 2020
  • Tweets868
  • Following658
  • Followers1K
39Media
Chad, Sarah, Brittany& Linda are all never-smokers with RET-positive #lungcancer. They are parents, siblings, friends & spouses. This is their story. #lcsm @StephenVLiu @NarjustFlorezMD @VivekSubbiah youtube.com/watch?v=UJwRfb53…
7
1
19
4,452
Proud to announce our collaboration with @23andme + 19 lung cancer advocacy groups to advance the Lung Cancer Genetics Study. US #lungcancer survivors: pls join & help us drive life-saving scientific discoveries. #lcsm 23andme.com/lung-cancer/?utm…
2
1
5
503
‼️ #ASCO24 simultaneous publication by Williams et al: CNS Protective Effect of Selpercatinib in First-Line RET Fusion-Positive Advanced #NSCLC: brnw.ch/21wKnSd
5
7
2,536
#ASCO24 Rapid Oral Presentation: Safety and efficacy of a selective RET inhibitor in pediatric and adolescent patients with RET-altered solid tumors. Results from the phase 1/2 LIBRETTO-121 study: e.lilly/4dVE5nU #CancerResearch #PrecisionMedicine
4
3
867
At #ASCO24, see our poster presentation examining a selective RET inhibitor in patients with non-MTC RET-mutated tumors. Results from the LIBRETTO-001 study: e.lilly/3x3gbpI #CancerResearch #PrecisionMedicine
2
2
669
At #ASCO24, we’re sharing intracranial outcomes data from LIBRETTO-431, a phase 3 study investigating front-line use of a selective RET inhibitor in patients with RET fusion+ advanced #NSCLC. Read the results here: e.lilly/4aB9ARm #CancerResearch #LungCancer #LCSM
1
2
670
Very important questions regarding management of other oncogene addicted nsclc in light of this data!
Stephen V Liu, MD
@StephenVLiu2 Jun 2024
Dr. @LeciaSequist with a brilliant #ASCO24 discussion of LAURA and #EGFR NSCLC. Do we apply this paradigm now to subtypes with CNS active agents that have long term safety data like #ALK and #RET? I think so!
1
4
515
Excellent discussion from @LeciaSequist We can’t do the same for all oncogene driven tumours. Worth considering if there is CNS penetration and low tox. Access will be issue. #LCSM #ASCO24
10
45
3,121
Our latest blog features @TejasPatilMD as he highlights the importance of teamwork in #lungcancerresearch and why his work to study #MET & #EGFR signaling pathways may help us overcome drug resistance in multiple types of lung cancer. lungevity.org/blogs/kicking-… #RET #lcsm
3
7
1,012
Every year since 2018 we have gathered 5 or more year survivors of lung cancer together at CU to show others that hope has a face. This is the May 11th 2024 gathering. Rock on!
32
35
9
216
24,132
Targeting EGFR and MET pathways to overcome resistance to targeted therapies. Thanks to the Hamoui Foundation, Lungevity, Dr. Patil and partners for this exciting research-- potentially relevant for multiple drivers! lungevity.org/blogs/kicking-…
1
2
5
472
@ros1cancer @ALKPositiveinc @EGFRResisters @ALKpositiveINT @TejasPatilMD @metcrusaders @RetRenegades @OncogeneCancer #lcsm
1
138
Double-dose osimertinib combined with intrathecal injection of pemetrexed improves the efficacy of EGFR-mutant non-small cell lung cancer and leptomeningeal metastasis: case report and literature review frontiersin.org/journals/onc…

Frontiers | Double-dose osimertinib combined with intrathecal injection of pemetrexed improves the...

Leptomeningeal metastasis (LM) is a complication of non-small cell lung cancer (NSCLC) characterized by poor prognosis and short survival. A variety of thera...

frontiersin.org
2
18
41
3,775
Thank you Dr. Watanabe, Lungevity and the patient community who helped fund this important research. #patientadvocacy #lcsm @LUNGevity
LUNGevity Foundation
@LUNGevity2 May 2024
In our latest blog, Dr. Hideo Watanabe (@IcahnMountSinai) shares updates on what is happening in his lab that could improve the long-term effectiveness of targeted therapy treatment for #lungcancer patients. Read here: bit.ly/3Qui7hI @RETpositive
1
6
691
In our latest blog, Dr. Hideo Watanabe (@IcahnMountSinai) shares updates on what is happening in his lab that could improve the long-term effectiveness of targeted therapy treatment for #lungcancer patients. Read here: bit.ly/3Qui7hI @RETpositive
4
1
3
1,344
Great news! biospace.com/article/release…

Ellipses' next generation selective RET inhibitor EP0031/A400 cleared to start Phase 2

Ellipses Pharma Limited announced the U.S. Food and Drug Administration has confirmed the company's next generation selective RET inhibitor, EP0031/A400, is clear to progress into Phase 2 clinical...

biospace.com
187
Big news for European #cancer #patients 🇪🇺 Selpercatinib has been approved by @EMA_News for advanced RET fusion positive solid tumours 🎯 This marks the 2nd tumour agnostic, biomarker-driven approval in the EU. #PrecisionMedicine @OncoAlert 🚨 ec.europa.eu/health/document…

Public Health - European Commission

Union Register of medicinal products

ec.europa.eu
4
16
2
56
5,238
RETpositive retweeted
FlorezLab
@Florez_Lab15 Apr 2024
📌Did You Know? 📌The FIRST International Pregnancy and Lung Cancer Registry has been created by the #FlorezLab, to understand the disease in this special population. 📌Anyone, ANYWHERE in the world can enter their own cases Email us📩: [email protected]
10
1
20
4,046
Don’t miss out! My colleague @TejasPatilMD presenting his exciting work on early MET bypass signaling in ALK and RET driven NSCLC. He is also an @CUCancerCenter Rising Star! @LUNGevity @ALKPositiveinc @RETpositive #LCSM #AACR24
1
6
1
22
5,696
Brittany, a young Mom & never-smoker, was diagnosed w/ #RET+ #lungcancer at 36. #IAmRETPositive #lcsm youtube.com/watch?v=e5bMyN_v…
3
6
709
Load more